• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • When it comes to Vascepa expansion, 'we can do this on our own' fiercepharma
    August 01, 2019
    Amarin’s fish-oil derivative Vascepa has been on a tear lately with a landmark outcomes trial and a $400 million cash raise in its rearview mirror. But taking the drug across the blockbuster plateau could present a challenge for a drugmaker as small as Am

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service